We performed our screening using phenazine derivatives that were previously shown to have an anti-tumor activity in pancreatic and prostatic cell lines [15, 16] and structure similar to inhibitors of the eIF4E/eIF4G interaction (Figure 2d). Here, EIF4G1 is linked to neoplasm.